anatabine has been researched along with Allergic Encephalomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoeng, J; Kolli, AR; Kondylis, A; Koshibu, K; Kuczaj, A; Martin, F; Peitsch, MC; Phillips, BW; Schneider, T; Talikka, M; Tan, G; Tan, WT; Teng, C; Vanscheeuwijck, P; Woon, K; Xia, W; Yeo, YS | 1 |
| Ait-Ghezala, G; Bachmeier, C; Beaulieu-Abdelahad, D; Crawford, F; Mathura, V; Mullan, M; Mullan, MJ; Paris, D | 1 |
2 other study(ies) available for anatabine and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Topics: Alkaloids; Animals; Anti-Inflammatory Agents; Brain; Carrageenan; Cytokines; Edema; Encephalomyelitis, Autoimmune, Experimental; Female; Male; Mice; Mice, Inbred C57BL; Pyridines; Rats; Rats, Wistar | 2021 |
Amelioration of experimental autoimmune encephalomyelitis by anatabine.
Topics: Administration, Oral; Alkaloids; Analysis of Variance; Animals; Blotting, Western; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Immunohistochemistry; Mice; Multiple Sclerosis; Pyridines; Th1 Cells; Th17 Cells | 2013 |